Ankerstar Wealth’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Ankerstar Wealth's PFE Position: Q3 2026 in Review
Ankerstar Wealth increased its Pfizer (PFE) stake by 1.1% in Q3 2026, buying an estimated $1.97K and bringing the position to 6,580 shares worth $188K. The position accounts for 0.15% of the portfolio, ranked #79.
Ankerstar Wealth first reported a position in PFE in Q4 2025 and has held it in 4 quarters since. 2,915 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Ankerstar Wealth held 6,580 shares of Pfizer worth $188K as of Q3 2026.
- Ankerstar Wealth bought 74 Pfizer shares in Q3 2026, an estimated $1.97K.
- Pfizer made up 0.15% of Ankerstar Wealth's portfolio in Q3 2026, its #79 holding.
- Ankerstar Wealth first reported a position in Pfizer in Q4 2025 and has held it in 4 quarters since.
- 2,915 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Ankerstar Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.